These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 30365097)
21. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
22. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373 [TBL] [Abstract][Full Text] [Related]
23. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547 [TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176 [TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1. Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914 [TBL] [Abstract][Full Text] [Related]
26. Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Sun D; Han S; Liu C; Zhou R; Sun W; Zhang Z; Qu J Med Sci Monit; 2016 Apr; 22():1210-7. PubMed ID: 27062921 [TBL] [Abstract][Full Text] [Related]
27. Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p. Chen L; Chen R; Velazquez VM; Brigstock DR Am J Pathol; 2016 Nov; 186(11):2921-2933. PubMed ID: 27662798 [TBL] [Abstract][Full Text] [Related]
28. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data. Wang YW; Zhang W; Ma R Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395 [TBL] [Abstract][Full Text] [Related]
29. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
30. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer. Berkel C; Cacan E Hum Cell; 2021 May; 34(3):862-877. PubMed ID: 33576947 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer. Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292 [TBL] [Abstract][Full Text] [Related]
32. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
33. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis. Ebrahimi SO; Reiisi S Arch Gynecol Obstet; 2019 May; 299(5):1453-1458. PubMed ID: 30810880 [TBL] [Abstract][Full Text] [Related]
35. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
36. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer. Li W; Lu Y; Yu X; Yong M; Ma D; Gao Q J Cell Biochem; 2019 Apr; 120(4):6361-6369. PubMed ID: 30304550 [TBL] [Abstract][Full Text] [Related]
38. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561 [TBL] [Abstract][Full Text] [Related]
39. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer. Liang Y; Zhang C; Ma MH; Dai DQ World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274 [TBL] [Abstract][Full Text] [Related]
40. Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients. Yunusova N; Dzhugashvili E; Yalovaya A; Kolomiets L; Shefer A; Grigor'eva A; Tupikin A; Kondakova I; Tamkovich S Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]